Secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the Efficacy of Response And Safety of 2 fixed secUkinumab REgimens in psoriasis (ERASURE)

被引：0
|
作者：
Elewski, B.
Lebwohl, M.
Papp, K.
Nakagawa, H.
Sigurgeirsson, B.
Tsai, T.
Tyring, S.
Hampele, I.
Karpov, A.
Helou, S.
Papavassilis, C.
机构：
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2014年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [41] Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study
    Costanzo, Antonio
    Russo, Filomena
    Galluzzo, Marco
    Stingeni, Luca
    Scuderi, Roberta
    Zichichi, Leonardo
    Papini, Manuela
    Di Costanzo, Luisa
    Conti, Andrea
    Burlando, Martina
    Chiricozzi, Andrea
    Gaiani, Francesca Maria
    Mugheddu, Cristina
    Musumeci, Maria Letizia
    Gisondi, Paolo
    Piaserico, Stefano
    Dapavo, Paolo
    Venturini, Marina
    Pagnanelli, Gianluca
    Amerio, Paolo
    Potenza, Concetta
    Peris, Ketty
    Cantoresi, Franca
    Trevisini, Sara
    Loconsole, Francesco
    Offidani, Annamaria
    Mercuri, Santo Raffaele
    Lora, Viviana
    Prignano, Francesca
    Bartezaghi, Marta
    Oliva, Giovanni
    Aloisi, Elisabetta
    Orsenigo, Roberto
    ACTA DERMATO-VENEREOLOGICA, 2021, 101
  • [42] Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study
    Costanzo, Antonio
    Russo, Filomena
    Galluzzo, Marco
    Stingeni, Luca
    Scuderi, Roberta
    Zichichi, Leonardo
    Papini, Manuela
    Di Costanzo, Luisa
    Conti, Andrea
    Burlando, Martina
    Chiricozzi, Andrea
    Gaiani, Francesca Maria
    Mugheddu, Cristina
    Musumeci, Maria Letizia
    Gisondi, Paolo
    Piaserico, Stefano
    Dapavo, Paolo
    Venturini, Marina
    Pagnanelli, Gianluca
    Amerio, Paolo
    Potenza, Concetta
    Peris, Ketty
    Cantoresi, Franca
    Trevisini, Sara
    Loconsole, Francesco
    Offidani, Annamaria
    Mercuri, Santo Raffaele
    Lora, Viviana
    Prignano, Francesca
    Bartezaghi, Marta
    Oliva, Giovanni
    Aloisi, Elisabetta
    Orsenigo, Roberto
    ACTA DERMATO-VENEREOLOGICA, 2021, 101
  • [43] Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective
    Lorenzo Mantovani
    Massimo Medaglia
    Patrizio Piacentini
    Marcella Tricca
    Gino Antonio Vena
    Antonietta Vozza
    Gabriella Castellino
    Alessandro Roccia
    Dermatology and Therapy, 2016, 6 : 151 - 167
  • [44] Correction to: Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis
    Hannah A. Blair
    Pediatric Drugs, 2022, 24 : 91 - 91
  • [45] Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective
    Mantovani, Lorenzo
    Medaglia, Massimo
    Piacentini, Patrizio
    Tricca, Marcella
    Vena, Gino Antonio
    Vozza, Antonietta
    Castellino, Gabriella
    Roccia, Alessandro
    DERMATOLOGY AND THERAPY, 2016, 6 (02) : 151 - 167
  • [46] Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials
    Kokolakis, Georgios
    Warren, Richard B.
    Strober, Bruce
    Blauvelt, Andrew
    Puig, Luis
    Morita, Akimichi
    Gooderham, Melinda
    Koerber, Andreas
    Vanvoorden, Veerle
    Wang, Maggie
    de Cuyper, Dirk
    Madden, Cynthia
    Gomez, Natalie Nunez
    Lebwohl, Mark
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (03) : 330 - 340
  • [47] Secukinumab efficacy and safety: Results from the First study of sEcukinumAb in prefilled syringes in subjecTs with chronic plaqUe-type psoriasis REsponse at 12 weeks (FEATURE)
    Paul, Carle
    Lacour, Jean-Philippe
    You, Ruquan
    Cooper, Simon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB185 - AB185
  • [48] Efficacy and safety of secukinumab by age group in patients with moderate-to-severe plaque psoriasis: Pooled analysis of 4 phase III trials
    Draelos, Zoe
    Kempers, Steven
    Helfrich, Yolanda
    Meng, Xiangyi
    Fox, Todd
    Nyirady, Judit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB247 - AB247
  • [49] Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and safety from the PROSPECT study
    Thaci, D.
    Koerber, A.
    von Kiedrowski, R.
    Bachhuber, T.
    Melzer, N.
    Kasparek, T.
    Duetting, E.
    Kraehn-Senftleben, G.
    Amon, U.
    Augustin, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (02) : 310 - 318
  • [50] Method of multiple Imputation confirms Efficacy of Secukinumab in practice: FIXTURE and ERASURE Data for moderate to severe Plaque-Psoriasis
    Reich, K.
    Langley, R. G.
    Fox, T.
    Gong, Y.
    Guettner, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 142 - 142
12345